Trial
NCT05893537
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Cognition Therapeutics
Collaborators
—
Condition
Age-Related Macular Degeneration
Intervention
Active Comparator CT1812
Why stopped
The trial was closed as part of a strategic business decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-16